Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin with or without hydroxychloroquine and azithromycin for COVID-19
PACTR202108891693522Phase 2Completed
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ivermectin, hydroxychloroquine and azithromycin in coronavirus disease 2019 (COVID-19) (2 arms). Primary endpoints: Proportion virologically negative by days 2, 5, 14 and 21 and Other virology outcomes. Started May 2021; status: completed.
02
Drugs
ivermectinhydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202108891693522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202108891693522.